Clorox (CLX) vs Innospec (IOSP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Innospec (IOSP) has outperformed Clorox (CLX) over the past year, gaining 24.4% versus a loss of 30.2%. Over five years, IOSP leads with a +14.0% price change compared with -48.9% for CLX. Clorox is the larger company by market cap ($10.09 billion vs $2.41 billion), about 4.2 times the size.
On valuation, Clorox trades at a lower forward P/E (13.4x vs 15.9x for Innospec). Clorox offers the higher dividend yield (5.96% vs 1.83%). Clorox converts more of its revenue into profit, with a net margin of 11.4% versus 6.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLX | IOSP |
|---|---|---|
| Share price | $83.44 | $97.69 |
| Market cap | $10.09B | $2.41B |
| 1-day change | +1.50% | +0.28% |
| YTD return | -17.25% | +27.63% |
| 1-year return | -30.23% | +24.45% |
| 5-year return | -48.89% | +13.99% |
| P/E ratio (TTM) | 17.35 | 19.94 |
| Forward P/E | 13.44 | 15.88 |
| EPS (TTM) | $4.81 | $4.90 |
| Dividend yield | 5.96% | 1.83% |
| Annual dividend | $4.97 | $1.79 |
| Revenue (latest FY) | $7.10B | $1.78B |
| Revenue growth (YoY) | +0.16% | -3.65% |
| Net income (latest FY) | $810.00M | $116.60M |
| Gross margin | 45.23% | 27.69% |
| Operating margin | — | 7.28% |
| Net margin | 11.40% | 6.56% |
| 52-week high | $128.90 | $100.48 |
| 52-week low | $79.12 | $65.51 |
| Distance from 52-week high | -35.27% | -2.78% |
| Analyst consensus | hold | none |
| Avg. price target upside | +19.36% | +3.39% |
| Average volume | 2.90M | 187.41K |
| Shares outstanding | 120.93M | 24.63M |
| Employees | 9,200 | 2,450 |
| Sector | Consumer Discretionary | Industrials |
| Industry | Specialty Chemicals | Major Chemicals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Clorox is about 4.2 times larger than Innospec by market value ($10.09B vs $2.41B).
- IOSP has outperformed CLX by 54.7 percentage points over the past year.
- Clorox offers a meaningfully higher dividend yield (5.96% vs 1.83%).
- The two companies sit in different sectors: Clorox in Consumer Discretionary and Innospec in Industrials.
About Clorox
CLX stock →The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International.
Consumer Discretionary · Specialty Chemicals · 9,200 employees
About Innospec
IOSP stock →Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific.
Industrials · Major Chemicals · 2,450 employees
CLX vs IOSP FAQ
Which is bigger, Clorox or Innospec?
Clorox (CLX) is larger, with a market capitalization of $10.09B compared with $2.41B for Innospec (IOSP).
Which stock has performed better over the past year, CLX or IOSP?
IOSP returned +24.45% over the past 12 months, compared with -30.23% for CLX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CLX or IOSP?
CLX has the lower trailing P/E at 17.3, versus 19.9 for IOSP. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Clorox or Innospec?
Clorox has the higher yield at 5.96%, compared with 1.83% for Innospec.
Are Clorox and Innospec in the same industry?
No. Clorox is in the Consumer Discretionary sector, while Innospec is in Industrials.